|
I.I. Shaposhnik
Such different sartans. Place of candesartan
|
№2 / 2017
|
|
A.G. Yevdokimova, Ye.V. Kovalenko, V.V. Yevdokimov, O.A. Shuiskaya
Potentials for the use of diuretic therapy in the clinic of internal diseases
|
№2 / 2017
|
|
A.N. Kuznetsov, N.Yu. Grigorieva, T.P. Ilyushina, M.B. Mayorova
Is there a relationship between bronchial asthma and arterial hypertension?
|
№1 / 2017
|
|
A.G. Yevdokimova, V.V. Yevdokimov, Ye.V. Kovalenko, K.I. Tebloyev
Clinical efficacy of fixed-dose combination antihypertensive therapy (focus on Hypotef)
|
№6 / 2016
|
|
V.A. Baturin, A.I. Elkanova
Pharmacoepidemiological study of ethnic differences in the use of antihypertensive drugs for hospital treatment of residents of the Karachay-Cherkess Republic
|
№5 / 2016
|
|
M.Ye. Statsenko, М.V. Derevyanchenko
Influence of the combined antihypertensive therapy on renal function and insulin resistance in patients with hypertension and type 2 diabetes
|
№5 / 2016
|
|
A.I. Martynov, Ye.V. Akatova, O.P. Nikolin, I.V. Urlaeva
Influence of magnesium orotate on cardiovascular risks
|
№5 / 2016
|
|
Ye.N. Dudinskaya, O.N. Tkacheva
Prospects for the use of moxonidine (Physiotens®) in the prevention of bone resorption and aging of the vascular wall
|
№4 / 2016
|
|
V.V. Cheltsov, Yu.Sh. Gushina, T.S. Illarioniva, E.А. Korovyakova, A.E. Moiseeva, A.P. Pereversev, Ye.Yu. Stefanenko, S.K. Ziryanov
Angiotensin II receptor blockers: focus on cardesartan
|
№4 / 2016
|
|
Yu.V. Zaviyalova, N.N. Borovkov, O.V. Zanozina, N.Yu. Borovkova
Peculiarities of arterial hypertension in patients with acromegaly in active phase
|
№4 / 2016
|
|
N.Yu. Grigorieva, A.N. Kuznetsov
Arterial hypertension and chronic bronchopulmonary diseases
|
№3 / 2016
|
|
Ye.I. Baranova, Ye.A. Polyakova
Antihypertensive therapy in patients with prediabetes and diabetes mellitus type 2
|
№3 / 2016
|
Русский
